This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:othertreatments:antitnf [05.02.2011] – external edit 127.0.0.1 | home:othertreatments:antitnf [01.03.2012] – external edit 127.0.0.1 | ||
---|---|---|---|
Line 77: | Line 77: | ||
* **Liver problems** – [[http:// | * **Liver problems** – [[http:// | ||
* **Skin problems** – In one prospective trial, 25% of patients on TNF-alpha-blocking therapy suffered from a dermatological condition that led them to visit a skin specialist. In a control group of patients who were not undergoing TNF-alpha blocking therapy and had less severe disease only 13% visited a dermatologist during the same period of time.(({{pubmed> | * **Skin problems** – In one prospective trial, 25% of patients on TNF-alpha-blocking therapy suffered from a dermatological condition that led them to visit a skin specialist. In a control group of patients who were not undergoing TNF-alpha blocking therapy and had less severe disease only 13% visited a dermatologist during the same period of time.(({{pubmed> | ||
- | * **Cancer** – One recent systematic review of the adverse effects of anti-TNF therapies as they were used in rheumatoid arthritis concluded that patients taking the drugs are at 3.3 times higher risk for " | + | * **Cancer** – One recent systematic review of the adverse effects of anti-TNF therapies as they were used in rheumatoid arthritis concluded that patients taking the drugs are at 3.3 times higher risk for " |
Line 99: | Line 99: | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
- | EDIT | + | |
* Legacy content | * Legacy content | ||
* http:// | * http:// | ||
===== References ===== | ===== References ===== |